➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for TAK-418

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug TAK-418?

TAK-418 is an investigational drug.

There have been 346 clinical trials for TAK-418. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2007.

The most common disease conditions in clinical trials are Diabetes Mellitus, Hypertension, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Takeda, Millennium Pharmaceuticals, Inc., and National Cancer Institute (NCI).

Recent Clinical Trials for TAK-418
A Study of TAK-994 in Adults With NarcolepsyTakedaPhase 2
Study to Evaluate Absorption, Metabolism, and Excretion, of TAK-994 in 6 Healthy Male AdultsTakedaPhase 1
Bioavailability and Food Effect Study of Two Formulations of TAK-906TakedaPhase 1

See all TAK-418 clinical trials

Clinical Trial Summary for TAK-418

Top disease conditions for TAK-418
Top clinical trial sponsors for TAK-418

See all TAK-418 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.